Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by u2bobon Apr 26, 2017 12:50pm
105 Views
Post# 26169104

RE:a better ccompany than a month ago.

RE:a better ccompany than a month ago. Hey Whippet found this statement interesting from the article I posted about Google...we are making in roads in these countries...also think are numbers look good...anyway this part was interesting as well... The system was able to detect and avoid the false negatives and false positives more than 91.5% of the times. The result exceeded National Institute of Healths accuracy and precision of 80%. Journal of American Medical Association released the results. On the other hand, a professor at Carnegie Mellon, known as Yaser Sheikh says this might become difficult in the developing world. There are certain barriers Read more at https://www.stockhouse.com/companies/bullboard/v.adk/diagnos-inc?postid=26168789#TpFbwIKStuXJ9As3.99
Bullboard Posts